CausalSentinel

Protein Dossier — OCIAD1 (OCIA domain-containing protein 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Myocardial infarction -0.121 0.0348 4.76e-04 Wald ratio 1 trans NA
Coronary heart disease -0.105 0.0315 8.64e-04 Wald ratio 1 trans NA
Amyotrophic lateral sclerosis -0.186 0.0571 0.00113 Wald ratio 1 trans NA
Eczema 0.168 0.0558 0.00266 Wald ratio 1 trans NA
Years of schooling -0.0372 0.0124 0.0027 Wald ratio 1 trans NA
Diagnoses - main ICD10: N92 Excessive frequent and irregular menstruation 0.134 0.0457 0.00341 Wald ratio 1 trans NA
Chronic kidney disease 0.136 0.0496 0.00596 Wald ratio 1 trans NA
Forced vital capacity (FVC) -0.0167 0.00614 0.00649 Wald ratio 1 trans NA
LDL cholesterol -0.0468 0.0174 0.00701 Wald ratio 1 trans NA
Sodium in urine 0.0186 0.00736 0.0115 Wald ratio 1 trans NA
Non-cancer illness code self-reported: deep venous thrombosis (dvt) -0.155 0.0622 0.0127 Wald ratio 1 trans NA
Heel bone mineral density (BMD) T-score automated 0.0237 0.00968 0.0143 Wald ratio 1 trans NA
…and 100 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3635_76_4 OCAD1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

14 association rows across 12 traits (12 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
COX5B protein levels 1e-66 rs112327139 1 GCST90468834 no MR -> candidate analysis
Age at menopause 7e-14 rs7665209 1 GCST007079 MR: beta=0.062, p=0.317 (trans)
ICAM4 protein levels 5e-13 rs201178302 1 GCST90469501 no MR -> candidate analysis
Pulse pressure 7e-13 rs13141838 1 GCST90310296 no MR -> candidate analysis
Type 2 diabetes 2e-12 rs62310934 2 GCST90492734 MR: beta=-0.0614, p=0.187 (trans)
Mean corpuscular hemoglobin 1e-11 rs7687992 1 GCST007068 no MR -> candidate analysis
Systolic blood pressure 5e-11 rs13141838 2 GCST90310294 MR: beta=0.0135, p=0.0773 (trans)
Medication use for hypertension (number of purchases) 4e-9 rs62310934 1 GCST90250905 no MR -> candidate analysis
Breast cancer 6e-9 rs4695407 1 GCST90308751 MR: beta=0.0549, p=0.0269 (trans)
Chronic sputum production 6e-9 rs79998532 1 GCST90269902 no MR -> candidate analysis
COVID-19 hospitalization or rheumatoid arthritis (MTAG) 3e-8 rs2354938 1 GCST90255368 no MR -> candidate analysis
Type 2 diabetes (PheCode 250.2) 1e-6 rs2354944 1 GCST90651113 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 129 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
breast carcinoma 0.141 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.123 common-variant locus no MR -> candidate analysis
migraine disorder 0.101 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.07 common-variant locus no MR -> candidate analysis

Of the 4 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (OCIA domain-containing protein 1)
gnomAD constraint pLI=4.7e-08, LOEUF=1.02 — LoF-tolerant
GWAS Catalog 48 unique SNPs / 96 rows
ClinVar 77 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance